SPRINT BIOSCIENCE AB revenue breakdown overview

SPRINT BIOSCIENCE AB revenue for the last year amounted to 71.00 M SEK, the most of which — 65.64 M SEK — came from its highest performing source at the moment, Cancer Drugs, the year earlier bringing 50.48 M SEK. The greatest contribution to the revenue figure was made by United States — last year it brought SPRINT BIOSCIENCE AB 65.62 M SEK, and the year before that — 50.45 M SEK.